 "Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical")
India has shipped 50 million tablets of hydroxychloroquine to the United States, an Indian source with direct knowledge of the exports said, although US regulators warned the anti-malarial drug may have harmful side effects in the treatment of COVID-19.
The trade, India's biggest export of the drug to any country, follows a request by US President Donald Trump for New Delhi to release supplies of hydroxychloroquine as a possible treatment for the respiratory disease.
"It amounts to 50 million tablets... Commercial companies are pursuing. It's ongoing," said the source, who declined to be identified due to the sensitivity of discussions with the
